REM SYSTEMS Veterinary is excited to announce that we will launch the HT Vista at Vet Expo on October 26-26th, 2022. HT Vista is a game changer, empowering vets to classify and detect cancer earlier.
HT Vista is the first non-invasive medical device that guides clinicians in making a determination whether subcutaneous and dermal masses are cancerous, quickly, affordably, and in the clinic.
HT Vista uses proprietary Heat Diffusion Imaging (HDI) technology which was developed by the company’s team of experts in the field of AI, signal analysis and computer vision, who worked hand-in-hand with heat transfer and thermodynamics researchers, oncologists and radiologists.
The HT Vista technology leverages the fact that normal and malignant tissues display different heat transfer rates, due to their differences in composition, metabolism, tissue morphology, and vascular network, which affect their thermophysical properties.
HT Vista performs a one-minute scan of the suspected mass, during which it measures the heat diffusion in the biological tissue. This innovative imaging modality relies on unique thermal signals recorded by the device as the tissue is heated and left to cool.
This thermal signal is then processed in the HT BioImaging’s cloud, using signal analysis and AI algorithms to identify abnormal tissue.
HT Vista delivers accurate results within minutes, providing a classification of the tested mass as benign, or further testing is required. This enables faster diagnosis and decision-making within the clinic.
Once HT Vista provides a negative result, with a 98% probability that the tumour is benign, the veterinarian can send the owner home without worry.
HT Vista has been tested on 400 dogs in clinical trials held in the US and Israel in collaboration with UC Davis and the Hebrew University of Israel.
